§01 · For BD leads opening new markets

You cannot build partnerships from a blank map.

Your job is to identify the right partners, qualify new accounts, and build relationships where you have no presence yet. That requires real intelligence about who is in the market and where the opportunities sit.

§02 · The situation

You open doors. Which doors?

Most BD leads spend two to three months manually piecing the market together. LinkedIn searches. Conference lists. Analyst reports from two years ago. Conversations that may or may not be representative.

By the time the picture comes into focus, the window has narrowed. Your competitors moved faster, not because they were smarter, but because they had better intelligence upfront.

NoordSight compresses that learning curve from months to 24 hours. A structured, sourced view of the entire landscape, tailored to your product and target buyer.

§03 · What you get

Intelligence built for people who open new markets for a living.

01

Partner and channel map

Distributors, integrators, resellers, and associations worth approaching. Their portfolio, their gaps, and how to open a conversation.

02

Strategic account shortlist

The companies whose problem shape matches your offer. Ranked by fit, with engagement rationale you can defend.

03

Ecosystem and influencer map

Research institutes, trade bodies, and the people whose endorsement accelerates access. Named and traceable.

04

Competitive whitespace

Where current players under-serve, where incumbents are vulnerable, where you can land before you expand.

§04 · Report excerpt

The partner map, at a glance.

app.noordsight.com/projects/france-medtech-channel

Channel strategy · France medtech

France channel map: distributor vs direct for medtech.

Three named distributors cover 71% of hospital procurement. Direct sales viable only above €2.4M ACV.

Analyst · Marta Kovac · Delivered 2026-04-15 10:22 CET

France operates 2,989 public and private hospitals, with CHU (university teaching) sites driving 58% of device spend 1 . Procurement is consolidated through three centrale d'achat: UniHA, RESAH, and UGAP. Vendors below €2.4M ACV cannot economically sustain the tender-response cycle required for direct sales.

Named distributor shortlist: Euromedis (Grenoble, 340 hospital accounts, margin 28-34%), Jaubert Medical (Bordeaux, specialist in surgical robotics, margin 22%), and Sté Bastide Le Confort Médical (listed on Euronext Paris 2 , 42% hospital share in Occitanie). All three have active dossiers for India-origin biosimilars and can provide CE-mark regulatory support via Bpifrance export-finance programmes.

Recommendation

Route through Euromedis for first 18 months: 4.2x faster CHU tender entry and no upfront localisation cost. Transition to direct when cumulative France ACV exceeds €3M.

"By week two I had signed the right distributor and three integrators in evaluation. The shortlist compressed six months of prospecting into an afternoon."

BD Lead · Industrial automation · EMEA expansion

Next step

Stop mapping the market by hand.

Start with an Explorer scan. Upgrade to a Go-to-Market partner map when you are ready to move.

Our guarantee

Delivered in 24 hours, or not at all.

Every report cites its sources. Every analyst signs their name. If the brief isn't answered, we revise free, or refund.

Details
§S · SOURCES
70+ DATABASES · SYNCED DAILY

NoordSight research agents retrieve from 70+ institutional databases, the same primary sources used by the World Bank, McKinsey, and the Economist Intelligence Unit. Every data point carries its citation from source to deliverable.

DATA RETRIEVED FROM PUBLIC INSTITUTIONAL DATABASES · THESE ORGANIZATIONS DO NOT ENDORSE NOORDSIGHT

Ready to move? European markets, decoded.
Get report